☰

Cheng-kui Qu - Publications

Affiliations: 
Pathology Case Western Reserve University, Cleveland Heights, OH, United States 
Area:
Pathology, Cell Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Xu D, Zheng H, Yu WM, Qu CK. Activating mutations in protein tyrosine phosphatase Ptpn11 (Shp2) enhance reactive oxygen species production that contributes to myeloproliferative disorder. Plos One. 8: e63152. PMID 23675459 DOI: 10.1371/Journal.Pone.0063152  0.353
2012 Yu W, Liu X, Shen J, Jovanovic O, Pohl EE, Gerson SL, Finkel T, Broxmeyer HE, Qu C. Disruption of Mitochondrial Phosphatase Ptpmt1 Induces Bioenergetic Stress and Differentiation Block in Hematopoietic Stem Cells Blood. 120: 857-857. DOI: 10.1182/Blood.V120.21.857.857  0.333
2012 Stavrou E, Fullana MJ, LaRusch G, Chang CY, Fang C, Meyerson HJ, Qu C, Yu W, Wnek GE, Schmaier AH. Leukocyte Factor XII Mediates Inflammation and Its Deficiency Promotes Wound Healing Blood. 120: 616-616. DOI: 10.1182/Blood.V120.21.616.616  0.306
2012 Liu W, Liu X, Qu C. Critical Role of the Gab2/PI3K/mTOR Pathway in the Pathogenesis of Ptpn11 (Shp2) Mutation-Induced Myeloproliferative Disease. Blood. 120: 2856-2856. DOI: 10.1182/Blood.V120.21.2856.2856  0.396
2011 Liu X, Qu CK. Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis. Journal of Signal Transduction. 2011: 195239. PMID 21799948 DOI: 10.1155/2011/195239  0.343
2011 Fischer SL, Zhao Y, Qu C, Sakthivel R. Ex Vivo Expansion of SCID Leukemia-Initiating Cells Using NANEX Nanofiber Scaffold Blood. 118: 4994-4994. DOI: 10.1182/Blood.V118.21.4994.4994  0.32
2011 Xu D, Liu X, Yu W, Meyerson HJ, Gerson SL, Qu C. Non-Lineage/Stage Restricted Effects of a Gain-of-Function Mutation in Tyrosine Phosphatase Ptpn11 (Shp2) on Malignant Transformation of Hematopoietic Cells Blood. 118: 392-392. DOI: 10.1182/Blood.V118.21.392.392  0.371
2010 Xu D, Wang S, Yu WM, Chan G, Araki T, Bunting KD, Neel BG, Qu CK. A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood. 116: 3611-21. PMID 20651068 DOI: 10.1182/blood-2010-01-265652  0.313
2010 Xu D, Wang S, Yu W, Chan G, Araki T, Bunting KD, Neel BG, Qu C. Abstract 4296A: Myeloproliferative disease induced by leukemogenic Ptpn11 (Shp-2) phosphatase arises from hematopoietic stem cells Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-4296A  0.377
2005 Yu W, Daino H, Chen J, Bunting KD, Qu C. Effects of a Leukemia-Associated Gain-of-Function Mutation of SHP-2 Phosphatase on IL-3 Signaling. Blood. 106: 2285-2285. DOI: 10.1182/Blood.V106.11.2285.2285  0.353
Show low-probability matches.